top of page
All Posts
Long-term Results From The Origin Phase 2B Study Of Atacicept For The Treatment Of IGA Nephropathy (IGAN)
Promising Long-Term Results for Atacicept in Treating IgA Nephropathy ▪        New findings from the ORIGIN Phase 2b study open-label...
2 min read
Novel DGAT2 Antisense Inhibitor Demonstrates Significant Histological Benefit In Biopsy-proven Mash Patients With Advanced Liver Fibrosis Stage F3: Subset Analysis Of A 51-week Multicenter Randomized
A recent analysis from the ION224-CS2 study has provided compelling evidence for the efficacy of ION224, a novel ligand-conjugated...
2 min read
Impact of Metabolic Diseases on Nucleos(t)ide Analogue Therapy in CHB: A Multi-centre Study
Metabolic conditions on treatment outcomes in CHB patients • With the global burden of metabolic diseases on the rise, their influence on...
2 min read
bottom of page